ES2526813T3 - Inhibidores de enzimas - Google Patents

Inhibidores de enzimas Download PDF

Info

Publication number
ES2526813T3
ES2526813T3 ES06820620.0T ES06820620T ES2526813T3 ES 2526813 T3 ES2526813 T3 ES 2526813T3 ES 06820620 T ES06820620 T ES 06820620T ES 2526813 T3 ES2526813 T3 ES 2526813T3
Authority
ES
Spain
Prior art keywords
mmol
imidazo
piperazine
pyridine
esi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06820620.0T
Other languages
English (en)
Spanish (es)
Inventor
Vassilios Bavetsias
Edward Macdonald
Spyridon Linardopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0526169A external-priority patent/GB0526169D0/en
Priority claimed from GB0620884A external-priority patent/GB0620884D0/en
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Application granted granted Critical
Publication of ES2526813T3 publication Critical patent/ES2526813T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES06820620.0T 2005-12-22 2006-12-21 Inhibidores de enzimas Active ES2526813T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0526169 2005-12-22
GB0526169A GB0526169D0 (en) 2005-12-22 2005-12-22 Enzyme inhibitors
GB0620884A GB0620884D0 (en) 2006-10-20 2006-10-20 Enzyme inhibitors
GB0620884 2006-10-20
PCT/GB2006/004854 WO2007072017A2 (en) 2005-12-22 2006-12-21 Enzyme inhibitors

Publications (1)

Publication Number Publication Date
ES2526813T3 true ES2526813T3 (es) 2015-01-15

Family

ID=38091678

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06820620.0T Active ES2526813T3 (es) 2005-12-22 2006-12-21 Inhibidores de enzimas

Country Status (5)

Country Link
US (1) US8088761B2 (enExample)
EP (1) EP1963315B1 (enExample)
JP (1) JP5205276B2 (enExample)
ES (1) ES2526813T3 (enExample)
WO (1) WO2007072017A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121064A1 (en) * 2007-03-30 2008-10-09 Astrazeneca Ab New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
WO2009001021A1 (en) * 2007-06-26 2008-12-31 Chroma Therapeutics Ltd. Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases
US8987307B2 (en) 2011-03-03 2015-03-24 Hoffmann-La Roche Inc. 3-amino-pyridines as GPBAR1 agonists
WO2013116291A1 (en) * 2012-01-30 2013-08-08 Cephalon, Inc. Imidazo [4, 5 - b] pyridine derivatives as alk and jak modulators for the treatment of proliferative disorders
SG11201406818VA (en) 2012-04-23 2014-11-27 Genentech Inc Intermediates and processes for preparing compounds
GB201211021D0 (en) * 2012-06-21 2012-08-01 Cancer Rec Tech Ltd Pharmaceutically active compounds
GB201211019D0 (en) * 2012-06-21 2012-08-01 Cancer Rec Tech Ltd Inhibitor compounds
ES2620119T3 (es) 2012-11-16 2017-06-27 Merck Patent Gmbh Derivados heterocíclicos novedosos como moduladores de la actividad de quinasa
UY36390A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
WO2016073738A2 (en) 2014-11-05 2016-05-12 Flexus Biosciences, Inc. Immunoregulatory agents
EP3253754B1 (en) 2015-02-02 2021-03-31 Kancera AB 2-phenyl-3h-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ror1 activity
US11660303B2 (en) 2016-07-11 2023-05-30 Kancera Ab 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
ES2899113T3 (es) 2016-07-11 2022-03-10 Kancera Ab Derivados de 2-fenilimidazo[4,5-b]piridin-7-amina útiles como inhibidores de la actividad tirosina quinasa ROR1 de mamíferos
CN112239465A (zh) 2019-07-16 2021-01-19 微境生物医药科技(上海)有限公司 极光激酶抑制剂及其用途
WO2024017977A1 (en) * 2022-07-20 2024-01-25 Sanofi Imidazopyridine compounds, preparation thereof and therapeutic uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24300A (id) * 1997-08-05 2000-07-13 Pfizer Prod Inc 4-AMINOPIROL(3,2-d)PIRIMIDIN SEBAGAI ANTAGONIS-ANTAGONIS RESEPTOR NEUROPEPTIDA Y
US6943174B2 (en) 2000-06-14 2005-09-13 Warner-Lambert Company 6,5-Fused bicyclic heterocycles
SE0202462D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor

Also Published As

Publication number Publication date
WO2007072017A2 (en) 2007-06-28
WO2007072017A3 (en) 2007-08-16
EP1963315B1 (en) 2014-10-08
EP1963315A2 (en) 2008-09-03
US8088761B2 (en) 2012-01-03
US20090247507A1 (en) 2009-10-01
JP2009520791A (ja) 2009-05-28
JP5205276B2 (ja) 2013-06-05

Similar Documents

Publication Publication Date Title
US11773110B2 (en) Heterocycle amines and uses thereof
ES2865374T3 (es) Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
ES2360933T3 (es) Derivados de heteroarilo condensados.
ES2526813T3 (es) Inhibidores de enzimas
US7547779B2 (en) Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
ES2400619T3 (es) Inhibidores de imidazopiridina quinasa
SK12472002A3 (sk) 5-Alkylpyrido[2,3-d]pyrimidínové inhibítory tyrosínových kináz
BRPI0713187A2 (pt) método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica
JP2007507547A (ja) キナーゼ阻害剤としての１，７−二置換アザベンゾイミダゾールの調製
CN102341400A (zh) 用作激酶抑制剂的吡咯并嘧啶化合物
WO2023224998A1 (en) Inhibitors of parg
JP2019514951A (ja) 増殖性疾患の治療に使用される置換２，４−ジアミノ−キノリン誘導体
AU2023271807A1 (en) Inhibitors of parg
JP2019519534A (ja) 五員複素環［３，４−ｄ］ピリダジノン系化合物、その製造方法、医薬組成物及び応用
WO2009001021A1 (en) Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases
JP7763538B2 (ja) Ｐａｒｐ７阻害剤及びその使用
ES2439918T3 (es) Compuestos de 1H-tieno[2,3-c]-pirazol útiles como inhibidores de cinasas
HK40083035B (zh) Parp7抑制剂及其用途
HK1197677B (en) Heterocycle amines and uses thereof
HK1197677A (en) Heterocycle amines and uses thereof
HK40001081A (en) Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases